CN102791149B - 生物活性食品添加剂 - Google Patents
生物活性食品添加剂 Download PDFInfo
- Publication number
- CN102791149B CN102791149B CN201080011447.9A CN201080011447A CN102791149B CN 102791149 B CN102791149 B CN 102791149B CN 201080011447 A CN201080011447 A CN 201080011447A CN 102791149 B CN102791149 B CN 102791149B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- excipient
- lactose
- calcium stearate
- ascorbic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000015872 dietary supplement Nutrition 0.000 title abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 8
- 239000008101 lactose Substances 0.000 claims abstract description 8
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims abstract description 7
- 235000013539 calcium stearate Nutrition 0.000 claims abstract description 7
- 239000008116 calcium stearate Substances 0.000 claims abstract description 7
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 6
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 6
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 6
- 229940046009 vitamin E Drugs 0.000 claims abstract description 6
- 239000011709 vitamin E Substances 0.000 claims abstract description 6
- 241000256844 Apis mellifera Species 0.000 claims description 11
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 10
- 241001074093 Echinopsis Species 0.000 claims description 8
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 8
- 235000011613 Pinus brutia Nutrition 0.000 claims description 8
- 241000018646 Pinus brutia Species 0.000 claims description 8
- 239000002131 composite material Substances 0.000 claims description 8
- 235000013373 food additive Nutrition 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 6
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 abstract description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 2
- 229930003268 Vitamin C Natural products 0.000 abstract description 2
- 235000019154 vitamin C Nutrition 0.000 abstract description 2
- 239000011718 vitamin C Substances 0.000 abstract description 2
- 241001426527 Rhaponticum Species 0.000 abstract 2
- 239000000454 talc Substances 0.000 abstract 2
- 229910052623 talc Inorganic materials 0.000 abstract 2
- 244000144987 brood Species 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- CIWBSHSKHKDKBQ-UHFFFAOYSA-N 2-(1,2-dihydroxyethyl)-3,4-dihydroxy-2h-furan-5-one Chemical compound OCC(O)C1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 230000000386 athletic effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 150000002061 ecdysteroids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001306755 Leuzea Species 0.000 description 1
- 208000025844 Prostatic disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 229940085398 ascorbic acid 50 mg Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940078456 calcium stearate Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000013442 quality metrics Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
Abstract
一种用于增加运动员肌肉质量的添加剂，包括菊科松漏芦属、雄幼蜂、抗坏血酸（维生素C）、维生素E和赋形剂（硬脂酸钙、滑石粉、乳糖），各组分的质量百分比如下：雄幼蜂1-70%；菊科松漏芦属5-70%；抗坏血酸1-70%；维生素E0.05-30%，硬脂酸钙0.92-0.95%；滑石粉3-6%；以及余量的乳糖。结果是所开发的食品添加剂能够实现使运动员的肌肉质量快速增长的技术效果。
Description
本发明涉及食品工业，特别是生物活性食品添加剂，并用于增强运动员的肌肉质量。
最好的生物刺激素和富含能量的产品包括以养蜂业产品为基础开发的制剂。已知的还有一种基于花粉和乳糖而开发的“Tonus”制剂，经RF总统的行政卫生部门批准使用(TU-64-02-06-244-91)，并由Biokor有限公司生产。
然而，该制剂不包含多种维生素复合物和重要的微量元素。它对人体的效果仅受花粉的影响，花粉可能会妨碍“Tonus”生物活性的鉴定，例如必须精确的知道采集花粉的时间和从什么植物上采集。就技术要点以及取得的效果来看，本发明最接近的现有技术是天然多种维生素复合物“Leveton”，RF专利号为2066963 МПКА23L001/076。它包含具有下述组分比例（质量%）的花粉（花粉团）、菊科松漏芦属（leuzea）、抗坏血酸维生素C、醋酸α-生育酚、蜂胶、硬脂酸钙、滑石粉以及乳糖：含有50-51%的花粉（花粉团）、10%的菊科松漏芦属、3.0-3.5%的抗坏血酸维生素C、0.15%的醋酸α-生育酚、2%的蜂胶、0.92-0.95%的硬脂酸钙、3%的滑石粉，其余组分为乳糖。
“Leveton”已经用于增加运动员的强度特性和肌肉质量，并且在高等体育院校中已经广泛使用了10余年。“Leveton”的效果受它的各组分之间的协同作用影响，所述组分指的是精确剂量的维生素和植物性蜕皮甾类的供体，也就是菊科松漏芦属和花粉（花粉团）。
本发明中，发明人发现用比花粉具有更强合成作用的雄幼蜂代替花粉（花粉团），它作为一种天然药物能够增加肌肉质量，保护肌肉使其不受生化损害并使其实现最好的效果。
雄幼蜂与花粉的不同之处在于它有许多硫化物酶的功能群和激素类，即睾酮、孕酮和雌二醇。由于具有这些物质，雄幼蜂作为雄性激素形成强度的中心调节机制的刺激剂，能够促进睾丸和前列腺的生化和质量公制参数的更好恢复。
其生化组分包括：10-20%的蛋白质，1-5.5%的碳水化合物，5-6.3%的脂肪，11.4%的氨基酸，3.18-5%的葡萄糖，最多达0.5%的果糖和蔗糖。
微量元素（mg%）包括：K 0.50, Na 38, Ca 14, P 189, Mg 2, Fe 3.23, Mn 4.40, Zn 5.54, Cu 2, Cr, Co, Ni, Ag, Au和其他。
维生素（水溶性和脂溶性）包括：维生素A 0.54 IU/g，叶黄素 0.297 mg%，B-胡萝卜素 0.426 IU/g，维生素B2 0.739 mg%，维生素D 950 IU/g，胆碱 442.8 mg%，烟酸 15.8 mg%。
在剧烈的肌肉活动期间，所述雄幼蜂能够增加新陈代谢水平，因为它使生理耐力增加。该雄幼蜂比花粉含有多10倍以上的类固醇激素。
截至今天，“Leveton”不能满足当前运动员肌肉质量迅速积累的需要，也不能确保重体力负荷之后疲劳肌肉的迅速恢复。与现有技术相比，本发明由于含有较高含量的植物蜕皮甾类，能够缩短运动员恢复过程。
上述技术效果能够实现是由于在已知的治疗-预防产品“Leveton”中加入了雄幼蜂，“Leveton”包含菊科松漏芦属（或一种含有蜕化类固醇的医用植物），抗坏血酸（维生素C）、维生素E以及赋形剂，将花粉团从组合物中移除后，选择的各组分比例（质量百分比）如下：雄幼蜂1-70%，菊科松漏芦属5-70%，抗坏血酸1-70%，维生素E 0.05-30%，以及余量的赋形剂。对于赋形剂而言，可使用的赋形剂如硬脂酸钙0.92-0.95%，滑石粉3-6%，以及余量的乳糖。
在使用科学技术和专利信息资源进行检索的过程中，发明人没有发现具有相似基本特征的集合且能够达到相同积极效果的物质。因此，本发明提供了一种解决该技术问题、并具有新颖性、创造性和工业实用性的技术方案。该治疗-预防性产品以片剂的形式生产。所述复合物使用的便利性（即使用较小量的片剂）决定了本发明的下限水平。而如果使用较大的百分率，片剂将破碎从而很难生产，这决定了上限水平。
实施例1
片剂质量为500g时混合配方的实施例
雄幼蜂 10mg
菊科松漏芦属（或一种含有蜕化类固醇的医用植物） 50mg
抗坏血酸 50mg
维生素E 5mg
赋形剂 385mg
因此，由于以菊科松漏芦属、雄幼蜂、抗坏血酸（微生物C）、微生物E、赋形剂为基础开发的所述食品添加剂具有增加的能够影响运动员体内合成代谢过程的植物性蜕皮甾类和植物激素的含量，可以作为增强运动员肌肉质量的产品。
这种产品不仅对人体有合成作用，而且被推荐用于预防中枢神经系统的机能障碍，以及用于治疗前列腺疾病和阳痿。
Claims (3)
1.一种食品添加剂，包括菊科松漏芦属、雄幼蜂、抗坏血酸、维生素E和赋形剂，各组分的质量百分比如下：
以及余量的赋形剂。
2.如权利要求1所述的食品添加剂，其中所述赋形剂包括硬脂酸钙、滑石粉和乳糖；所述雄幼蜂的生化组分包括：10-20％的蛋白质，1-5.5％的碳水化合物，5-6.3％的脂肪，11.4％的氨基酸，3.18-5％的葡萄糖，0.5％的果糖和蔗糖。
3.如权利要求2所述的一种食品添加剂，其中赋形剂包括质量百分比为：0.92-0.95％的硬脂酸钙，3-6％的滑石粉，以及余量的乳糖。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009109273 | 2009-03-13 | ||
| RU2009109273/13A RU2390270C1 (ru) | 2009-03-13 | 2009-03-13 | Биологически активная добавка к пище |
| PCT/RU2010/000098 WO2010104418A1 (ru) | 2009-03-13 | 2010-03-03 | Биологически активная добавка к пище |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102791149A CN102791149A (zh) | 2012-11-21 |
| CN102791149B true CN102791149B (zh) | 2015-05-27 |
Family
ID=42680298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201080011447.9A Expired - Fee Related CN102791149B (zh) | 2009-03-13 | 2010-03-03 | 生物活性食品添加剂 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20120003200A1 (zh) |
| EP (1) | EP2407035B1 (zh) |
| CN (1) | CN102791149B (zh) |
| CA (1) | CA2793071C (zh) |
| DK (1) | DK2407035T3 (zh) |
| EA (1) | EA019184B1 (zh) |
| ES (1) | ES2625294T3 (zh) |
| LT (1) | LT2407035T (zh) |
| PL (1) | PL2407035T3 (zh) |
| RU (1) | RU2390270C1 (zh) |
| UA (1) | UA108465C2 (zh) |
| WO (1) | WO2010104418A1 (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2414229C1 (ru) * | 2009-10-12 | 2011-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Лекарственное средство для профилактики и лечения аденомы и простатита |
| RU2425593C1 (ru) * | 2010-05-04 | 2011-08-10 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для нормализации уровня андрогенов мужчин, общего состояния, снижения ожирения |
| RU2458537C1 (ru) * | 2011-03-14 | 2012-08-20 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин |
| RU2456005C1 (ru) * | 2011-04-20 | 2012-07-20 | Общество с ограниченной ответственностью фирма "Биокор" | Способ приготовления биологически активного препарата |
| RU2493733C2 (ru) * | 2011-07-05 | 2013-09-27 | Общество С Ограниченной Ответственностью "Парафарм" | Тонизирующий напиток |
| RU2509569C2 (ru) * | 2011-07-05 | 2014-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Композиция для лечения и предупреждения остеоартрита и остеоартроза суставов |
| RU2491078C2 (ru) * | 2011-09-16 | 2013-08-27 | Общество С Ограниченной Ответственностью "Парафарм" | Способ приготовления расплода трутневого адсорбированного и его состав |
| RU2561863C1 (ru) * | 2014-03-12 | 2015-09-10 | Автономная некоммерческая организация содействия социально-экономическому развитию "ИНЖЭКОН-Тверь" | Способ изготовления биологического стимулятора |
| US9700589B2 (en) * | 2015-02-03 | 2017-07-11 | Naturex Sa | Compositions and methods for improved muscle metabolism |
| RU2577225C1 (ru) * | 2015-03-27 | 2016-03-10 | Общество С Ограниченной Ответственностью "Парафарм" | Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины |
| FR3078252B1 (fr) * | 2018-02-28 | 2020-08-14 | Biophytis | Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation |
| RU2679361C1 (ru) * | 2018-03-29 | 2019-02-07 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") | Способ получения биогенного стимулятора для коррекции иммунного статуса сельскохозяйственных животных |
| RU2745997C1 (ru) * | 2019-11-28 | 2021-04-05 | Общество с ограниченной ответственностью "Фармацевтический завод "ГАЛЕН" | Биологически активная композиция, обладающая адаптогенным и антистрессорным действием |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1028200C (zh) * | 1988-09-07 | 1995-04-19 | 刘本华 | 雄蜂营养素的提取方法 |
| RU1826910C (ru) * | 1991-05-12 | 1993-07-07 | В.А.Чуйко и Г.Н.Спиридонова | Биостимулирующее средство |
| RU2066963C1 (ru) * | 1993-10-20 | 1996-09-27 | Рошен Джафарович Сейфулла | Натуральный поливитаминный комплекс "леветон" |
| CN1097308A (zh) * | 1994-04-13 | 1995-01-18 | 唐国山 | 雄蜂神液 |
| DE19627627C2 (de) * | 1996-07-09 | 2003-06-18 | Bienenzell Gmbh | Verfahren zur Herstellung eines Bienenbrutsaft-Extraktes |
| RU2149566C1 (ru) * | 1997-11-19 | 2000-05-27 | Сейфулла Рошен Джафарович | Натуральный поливитаминный комплекс "астенотон" |
| CN1274319C (zh) * | 2000-07-18 | 2006-09-13 | 沈阳药科大学 | 中药漏芦中植物甾酮类成分的用途 |
| RU2216346C1 (ru) * | 2002-06-10 | 2003-11-20 | Семенова Наталья Викторовна | Средство и способ для биогенной стимуляции организма |
| RU2233666C1 (ru) * | 2002-12-30 | 2004-08-10 | Пятигорская государственная фармацевтическая академия | Таблетки "апилар" на основе трутневого расплода, обладающие анаболическим, актопротекторным действием |
-
2009
- 2009-03-13 RU RU2009109273/13A patent/RU2390270C1/ru active
-
2010
- 2010-03-03 EA EA201100167A patent/EA019184B1/ru unknown
- 2010-03-03 PL PL10751072T patent/PL2407035T3/pl unknown
- 2010-03-03 WO PCT/RU2010/000098 patent/WO2010104418A1/ru active Application Filing
- 2010-03-03 CA CA2793071A patent/CA2793071C/en active Active
- 2010-03-03 US US13/256,237 patent/US20120003200A1/en not_active Abandoned
- 2010-03-03 EP EP10751072.9A patent/EP2407035B1/en active Active
- 2010-03-03 CN CN201080011447.9A patent/CN102791149B/zh not_active Expired - Fee Related
- 2010-03-03 LT LTEP10751072.9T patent/LT2407035T/lt unknown
- 2010-03-03 UA UAA201103548A patent/UA108465C2/ru unknown
- 2010-03-03 ES ES10751072.9T patent/ES2625294T3/es active Active
- 2010-03-03 DK DK10751072.9T patent/DK2407035T3/en active
-
2013
- 2013-12-23 US US14/138,875 patent/US20140314870A1/en not_active Abandoned
-
2016
- 2016-03-06 US US15/062,161 patent/US10064421B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2407035A1 (en) | 2012-01-18 |
| ES2625294T3 (es) | 2017-07-19 |
| LT2407035T (lt) | 2017-04-10 |
| CN102791149A (zh) | 2012-11-21 |
| EA019184B1 (ru) | 2014-01-30 |
| US20140314870A1 (en) | 2014-10-23 |
| EP2407035B1 (en) | 2017-02-22 |
| RU2390270C1 (ru) | 2010-05-27 |
| PL2407035T3 (pl) | 2017-07-31 |
| US10064421B2 (en) | 2018-09-04 |
| DK2407035T3 (en) | 2017-04-10 |
| WO2010104418A1 (ru) | 2010-09-16 |
| EA201100167A1 (ru) | 2011-06-30 |
| US20160192687A1 (en) | 2016-07-07 |
| UA108465C2 (en) | 2015-05-12 |
| CA2793071C (en) | 2018-11-13 |
| US20120003200A1 (en) | 2012-01-05 |
| EP2407035A4 (en) | 2013-01-02 |
| CA2793071A1 (en) | 2010-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102791149B (zh) | 生物活性食品添加剂 | |
| CN101317684B (zh) | 一种固体饮料及制作方法 | |
| CN105166923A (zh) | 一种玉米肽保健食品及制作方法 | |
| CN102475173A (zh) | 一种减肥茶及其制备方法 | |
| CN102172289A (zh) | 高吸收利用率的复合胶原蛋白冲剂及其制备方法 | |
| CN103478561A (zh) | 一种具有抗氧化和延缓衰老作用的功能食品的制备方法 | |
| JP2006197911A (ja) | 蜂の子利用の健康食品。 | |
| RU2533040C2 (ru) | Состав для приготовления фитоджема (варианты) | |
| CN106387451A (zh) | 一种促进断奶羔羊生长发育的中药添加剂及其饲料 | |
| KR100819491B1 (ko) | 유해성분이 제거된 유황의 제조방법 | |
| CN101530227A (zh) | 鱼腥草刺梨饮料 | |
| CN105028854A (zh) | 氨基酸玛卡压片糖果及其制备方法与用途 | |
| CN106810323A (zh) | 一种用于培育富钙富硒食用菌的培养基 | |
| CN101513259B (zh) | 一种补钙产品 | |
| CN101204215A (zh) | 利用天然辣椒碱制备的水溶性、油溶性、粉末性辣椒精 | |
| CN105029271A (zh) | 一种盐地碱蓬咀嚼片及其制备方法 | |
| CN110419646A (zh) | 一种鱼用饲料添加剂的制备方法和应用 | |
| CN105029413A (zh) | 玛咖保健组合物 | |
| CN106309551A (zh) | 一种紫苏复方制剂及其制备方法 | |
| CN102366104B (zh) | 一种用于肿瘤患者的营养食品 | |
| CN103005078A (zh) | 一种牛蒡保健茶及其制备方法 | |
| KR20090099141A (ko) | 보리순을 주재료로 하는 건강음료용 조성물 | |
| CN1895328B (zh) | 柿科植物材料在制备耐缺氧抗疲劳用组合物中的应用 | |
| RU2141772C1 (ru) | Композиция ингредиентов для биологически активной добавки к пище "аралиевая" | |
| CN103461270A (zh) | 一种具有减肥功能鸡蛋的生产方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150527 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |